New Appointments on IVI Management Team
- New Deputy Director General of Government Affairs & Governance, Head of Biostatistics, and Head of Program Management onboard
These new appointments reflect the strategic and organizational changes taking place at IVI since January, 2016. Key hires and appointments have been made over the past few months as part of IVI’s strategic renewal. These individuals bring seniority and experience in vaccine-related research and management to IVI, and they are instrumental in bolstering IVI’s scientific leadership, management and operations.
Dr. Han, Kyung-Taik is the Deputy Director General of IVI’s Government Affairs & Governance Unit as of April 4, 2016. This newly established unit will oversee engagement with the Korean government and other stakeholders in the Republic of Korea (IVI’s host country), and ensure that governance and internal control are in compliance with donor requirements and international accounting standards. As Deputy Director General, Dr. Han will also serve on IVI’s leadership team.
Dr. Han has more than 30 years’ experience as a senior official in the South Korean government in areas that include economic policy, budgeting and planning, and trade. Among his positions were Director General of the Technology & Safety Policy Bureau, Ministry of Construction and Transportation; Director General of the Policy Analysis Bureau, National Economic Advisory Council; and Chief Executive Auditor of the Korea Credit Guarantee Fund. He previously worked with IVI as a consultant, providing support and guidance on government issues. He is the Non-Executive Director of Daewoo Shipbuilding and Marine Engineering Co., Ltd. and an Adjunct Professor at the College of Business and Technology of Seoul National University of Science and Technology. Dr. Han has a Ph.D. in economics from the University of Hawaii; Master of Science degree in management science from the Korea Advanced Institute of Science and Technology (KAIST); and Master of Public Administration degree and Bachelor of Arts degree in economics from Seoul National University. He is an Internal Auditor certified by the Institute of Internal Auditors, U.S.A.
Dr. Julia A. Lynch is the Head of IVI’s Program Management Unit, effective May 6, 2016. This unit will be responsible for project management and grant management.
Prior to IVI, she served 29 years in the U.S. Army. Dr. Lynch first served as Director of the Division of Viral Diseases at the Walter Reed Army Institute of Research during which significant studies were conducted for Japanese encephalitis, adenovirus and dengue vaccines. She was appointed Director of the Military Infectious Disease Research Program at Fort Detrick, Maryland, a product development program targeting vaccines against malaria, dengue and enteric pathogens, as well as new anti-parasitic drugs and infectious disease diagnostics for resource limited settings. She later became the Science Director for the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand, where she was responsible for activities spanning eight countries in South-East Asia that included biosurveillance, basic science, pre-clinical studies and human clinical trials. Dr. Lynch received her M.D. from Columbia University and completed a Pediatric Residency and Infectious Disease fellowship at the Walter Reed Army Medical Center.
Dr. Yun Chon is the Head of IVI’s Biostatistics & Data Management Department as of April 1, 2016. This department, under the Development & Delivery Unit, is responsible for biostatistics and data management in support of IVI’s research activities including epidemiologic and clinical studies. The department also provides training and technical support to IVI collaborators and their research activities from middle- and low-income countries.
Prior to IVI, she was the Director of Biostatistics, Clinical Development, Global Biostatistical Science at Amgen Inc. for 12 years leading a statistical group participating various phases of drug development clinical trials and observation studies. Her interest of research includes adaptive design in clinical trial and repeated measure analysis. As a senior biostatistician at BASEUNIT, Department of Biomathematics, University of California Los Angeles (UCLA) for 14 years, Dr. Chon conducted statistical research in support of AIDS research and clinical studies at UCLA medical center, and led coordinating centers for multi-center clinical trials funded by the U.S. National Institutes of Health and National Cancer Institute in areas such as breast cancer, prostate cancer, liver cancer, and pulmonary function disease. She also served as statistics lecturer for a summer training program for new fellows at UCLA’s clinical research center and cancer center. She was also a reviewer for the Journal of Biopharmaceutical Statistics and Contemporary Clinical Trials. Dr. Chon has a Ph.D and Master of Science degree in biostatistics from UCLA, and a Master of Science degree and Bachelor of Science degree in mathematics from Yonsei University.